NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,562 | -4.3% | 1,969 | -14.7% | 0.08% | -10.1% |
| Q4 2022 | $209,504 | -7.7% | 2,309 | -14.2% | 0.09% | -16.8% |
| Q2 2022 | $227,000 | -47.0% | 2,691 | -44.9% | 0.11% | -38.5% |
| Q1 2022 | $428,000 | -75.9% | 4,881 | -75.9% | 0.17% | -74.9% |
| Q4 2021 | $1,775,000 | -20.5% | 20,295 | -25.6% | 0.69% | -24.7% |
| Q3 2021 | $2,232,000 | +4.2% | 27,295 | +16.2% | 0.92% | +7.6% |
| Q2 2021 | $2,142,000 | +13.7% | 23,481 | +6.5% | 0.85% | +8.1% |
| Q1 2021 | $1,884,000 | +29.1% | 22,043 | +42.7% | 0.79% | +23.1% |
| Q4 2020 | $1,459,000 | +35.6% | 15,450 | +24.9% | 0.64% | +0.8% |
| Q3 2020 | $1,076,000 | +33.8% | 12,370 | +34.3% | 0.64% | +20.4% |
| Q2 2020 | $804,000 | +35.6% | 9,211 | +28.0% | 0.53% | -1.7% |
| Q1 2020 | $593,000 | +15.6% | 7,194 | +32.8% | 0.54% | +26.0% |
| Q4 2019 | $513,000 | +8.9% | 5,417 | 0.0% | 0.43% | -3.2% |
| Q3 2019 | $471,000 | -2.1% | 5,417 | +2.8% | 0.44% | -1.3% |
| Q2 2019 | $481,000 | +16.7% | 5,272 | +23.0% | 0.45% | +14.0% |
| Q1 2019 | $412,000 | +22.3% | 4,286 | +9.2% | 0.39% | +18.4% |
| Q4 2018 | $337,000 | – | 3,926 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |